APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadoterate Meglumine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gadoterate Meglumine Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchGadoterate Meglumine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadoterate Meglumine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Gadoterate Meglumine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadoterate Meglumine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadoterate Meglumine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Gadoterate Meglumine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gadoterate Meglumine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gadoterate Meglumine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gadoterate Meglumine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gadoterate Meglumine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gadoterate Meglumine include Hengrui Medicine, Guerbet Group and GE Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gadoterate Meglumine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gadoterate Meglumine, also provides the sales of main regions and countries. Of the upcoming market potential for Gadoterate Meglumine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gadoterate Meglumine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gadoterate Meglumine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gadoterate Meglumine sales, projected growth trends, production technology, application and end-user industry.

Gadoterate Meglumine Segment by Company

Hengrui Medicine

Guerbet Group

GE Healthcare

Gadoterate Meglumine Segment by Type

5.6535Gm/15Ml

3.769Gm/10Ml

1.8845Gm/5Ml

Others

Gadoterate Meglumine Segment by Application

Hospitals

Clinics

Gadoterate Meglumine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadoterate Meglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadoterate Meglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadoterate Meglumine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gadoterate Meglumine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gadoterate Meglumine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gadoterate Meglumine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gadoterate Meglumine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5.6535Gm/15Ml Major Manufacturers Table 3. 3.769Gm/10Ml Major Manufacturers Table 4. 1.8845Gm/5Ml Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Gadoterate Meglumine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Manufacturers Table 8. Clinics Major Manufacturers Table 9. Gadoterate Meglumine Industry Trends Table 10. Gadoterate Meglumine Industry Drivers Table 11. Gadoterate Meglumine Industry Opportunities and Challenges Table 12. Gadoterate Meglumine Industry Restraints Table 13. Global Gadoterate Meglumine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Gadoterate Meglumine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Gadoterate Meglumine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Gadoterate Meglumine Revenue Market Share by Region (2021-2026) Table 17. Global Gadoterate Meglumine Revenue Market Share by Region (2027-2032) Table 18. Global Gadoterate Meglumine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K L) Table 19. Global Gadoterate Meglumine Sales by Region (2021-2026) & (K L) Table 20. Global Gadoterate Meglumine Sales by Region (2027-2032) & (K L) Table 21. Global Gadoterate Meglumine Sales Market Share by Region (2021-2026) Table 22. Global Gadoterate Meglumine Sales Market Share by Region (2027-2032) Table 23. Global Gadoterate Meglumine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Gadoterate Meglumine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gadoterate Meglumine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Gadoterate Meglumine Sales Price (US$/L) of Manufacturers (2021-2026) Table 28. Global Gadoterate Meglumine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Gadoterate Meglumine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Gadoterate Meglumine Manufacturers, Product Type & Application Table 31. Global Gadoterate Meglumine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Gadoterate Meglumine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Gadoterate Meglumine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gadoterate Meglumine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Gadoterate Meglumine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Gadoterate Meglumine Revenue Market Share by Type (2021-2026) Table 38. Global Gadoterate Meglumine Revenue Market Share by Type (2027-2032) Table 39. Global Gadoterate Meglumine Sales by Type 2021 VS 2025 VS 2032 (K L) Table 40. Global Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 41. Global Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 42. Global Gadoterate Meglumine Sales Market Share by Type (2021-2026) Table 43. Global Gadoterate Meglumine Sales Market Share by Type (2027-2032) Table 44. Global Gadoterate Meglumine Price by Type (2021-2026) & (US$/L) Table 45. Global Gadoterate Meglumine Price by Type (2027-2032) & (US$/L) Table 46. Global Gadoterate Meglumine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Gadoterate Meglumine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Gadoterate Meglumine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Gadoterate Meglumine Revenue Market Share by Application (2021-2026) Table 50. Global Gadoterate Meglumine Revenue Market Share by Application (2027-2032) Table 51. Global Gadoterate Meglumine Sales by Application 2021 VS 2025 VS 2032 (K L) Table 52. Global Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 53. Global Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 54. Global Gadoterate Meglumine Sales Market Share by Application (2021-2026) Table 55. Global Gadoterate Meglumine Sales Market Share by Application (2027-2032) Table 56. Global Gadoterate Meglumine Price by Application (2021-2026) & (US$/L) Table 57. Global Gadoterate Meglumine Price by Application (2027-2032) & (US$/L) Table 58. Hengrui Medicine Company Information Table 59. Hengrui Medicine Business Overview Table 60. Hengrui Medicine Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 61. Hengrui Medicine Gadoterate Meglumine Product Portfolio Table 62. Hengrui Medicine Recent Development Table 63. Guerbet Group Company Information Table 64. Guerbet Group Business Overview Table 65. Guerbet Group Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 66. Guerbet Group Gadoterate Meglumine Product Portfolio Table 67. Guerbet Group Recent Development Table 68. GE Healthcare Company Information Table 69. GE Healthcare Business Overview Table 70. GE Healthcare Gadoterate Meglumine Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 71. GE Healthcare Gadoterate Meglumine Product Portfolio Table 72. GE Healthcare Recent Development Table 73. North America Gadoterate Meglumine Revenue by Type (2021-2026) & (US$ Million) Table 74. North America Gadoterate Meglumine Revenue by Type (2027-2032) & (US$ Million) Table 75. North America Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 76. North America Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 77. North America Gadoterate Meglumine Sales Price by Type (2021-2026) & (US$/L) Table 78. North America Gadoterate Meglumine Sales Price by Type (2027-2032) & (US$/L) Table 79. North America Gadoterate Meglumine Revenue by Application (2021-2026) & (US$ Million) Table 80. North America Gadoterate Meglumine Revenue by Application (2027-2032) & (US$ Million) Table 81. North America Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 82. North America Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 83. North America Gadoterate Meglumine Sales Price by Application (2021-2026) & (US$/L) Table 84. North America Gadoterate Meglumine Sales Price by Application (2027-2032) & (US$/L) Table 85. North America Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Gadoterate Meglumine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 87. North America Gadoterate Meglumine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 88. North America Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 89. North America Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 90. North America Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 91. North America Gadoterate Meglumine Sales Price by Country (2021-2026) & (US$/L) Table 92. North America Gadoterate Meglumine Sales Price by Country (2027-2032) & (US$/L) Table 93. United States Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 94. Canada Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 95. Europe Gadoterate Meglumine Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Gadoterate Meglumine Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 98. Europe Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 99. Europe Gadoterate Meglumine Sales Price by Type (2021-2026) & (US$/L) Table 100. Europe Gadoterate Meglumine Sales Price by Type (2027-2032) & (US$/L) Table 101. Europe Gadoterate Meglumine Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Gadoterate Meglumine Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 104. Europe Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 105. Europe Gadoterate Meglumine Sales Price by Application (2021-2026) & (US$/L) Table 106. Europe Gadoterate Meglumine Sales Price by Application (2027-2032) & (US$/L) Table 107. Europe Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Gadoterate Meglumine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Gadoterate Meglumine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 111. Europe Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 112. Europe Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 113. Europe Gadoterate Meglumine Sales Price by Country (2021-2026) & (US$/L) Table 114. Europe Gadoterate Meglumine Sales Price by Country (2027-2032) & (US$/L) Table 115. Germany Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 116. France Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 117. U.K. Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 118. Italy Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 119. Netherlands Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 120. China Gadoterate Meglumine Revenue by Type (2021-2026) & (US$ Million) Table 121. China Gadoterate Meglumine Revenue by Type (2027-2032) & (US$ Million) Table 122. China Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 123. China Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 124. China Gadoterate Meglumine Sales Price by Type (2021-2026) & (US$/L) Table 125. China Gadoterate Meglumine Sales Price by Type (2027-2032) & (US$/L) Table 126. China Gadoterate Meglumine Revenue by Application (2021-2026) & (US$ Million) Table 127. China Gadoterate Meglumine Revenue by Application (2027-2032) & (US$ Million) Table 128. China Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 129. China Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 130. China Gadoterate Meglumine Sales Price by Application (2021-2026) & (US$/L) Table 131. China Gadoterate Meglumine Sales Price by Application (2027-2032) & (US$/L) Table 132. Asia Gadoterate Meglumine Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Gadoterate Meglumine Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 135. Asia Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 136. Asia Gadoterate Meglumine Sales Price by Type (2021-2026) & (US$/L) Table 137. Asia Gadoterate Meglumine Sales Price by Type (2027-2032) & (US$/L) Table 138. Asia Gadoterate Meglumine Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Gadoterate Meglumine Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 141. Asia Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 142. Asia Gadoterate Meglumine Sales Price by Application (2021-2026) & (US$/L) Table 143. Asia Gadoterate Meglumine Sales Price by Application (2027-2032) & (US$/L) Table 144. Asia Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Gadoterate Meglumine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Gadoterate Meglumine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 148. Asia Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 149. Asia Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 150. Asia Gadoterate Meglumine Sales Price by Country (2021-2026) & (US$/L) Table 151. Asia Gadoterate Meglumine Sales Price by Country (2027-2032) & (US$/L) Table 152. Japan Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 153. South Korea Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 154. India Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 155. Australia Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 156. China Taiwan Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Gadoterate Meglumine Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Gadoterate Meglumine Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Gadoterate Meglumine Sales by Type (2021-2026) & (K L) Table 161. SAMEA Gadoterate Meglumine Sales by Type (2027-2032) & (K L) Table 162. SAMEA Gadoterate Meglumine Sales Price by Type (2021-2026) & (US$/L) Table 163. SAMEA Gadoterate Meglumine Sales Price by Type (2027-2032) & (US$/L) Table 164. SAMEA Gadoterate Meglumine Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Gadoterate Meglumine Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Gadoterate Meglumine Sales by Application (2021-2026) & (K L) Table 167. SAMEA Gadoterate Meglumine Sales by Application (2027-2032) & (K L) Table 168. SAMEA Gadoterate Meglumine Sales Price by Application (2021-2026) & (US$/L) Table 169. SAMEA Gadoterate Meglumine Sales Price by Application (2027-2032) & (US$/L) Table 170. SAMEA Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Gadoterate Meglumine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Gadoterate Meglumine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032) & (K L) Table 174. SAMEA Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 175. SAMEA Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 176. SAMEA Gadoterate Meglumine Sales Price by Country (2021-2026) & (US$/L) Table 177. SAMEA Gadoterate Meglumine Sales Price by Country (2027-2032) & (US$/L) Table 178. Brazil Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 179. Argentina Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 180. Chile Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 181. Colombia Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 182. Peru Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 184. Israel Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 185. UAE Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 186. Turkey Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 187. Iran Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 188. Egypt Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Gadoterate Meglumine Distributors List Table 192. Gadoterate Meglumine Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Gadoterate Meglumine Image Figure 2. Global Gadoterate Meglumine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadoterate Meglumine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5.6535Gm/15Ml Image Figure 5. 3.769Gm/10Ml Image Figure 6. 1.8845Gm/5Ml Image Figure 7. Others Image Figure 8. Global Gadoterate Meglumine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Gadoterate Meglumine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Global Gadoterate Meglumine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gadoterate Meglumine Revenue (2021-2032) & (US$ Million) Figure 14. Global Gadoterate Meglumine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Gadoterate Meglumine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Gadoterate Meglumine Revenue Market Share by Region (2021-2032) Figure 17. Global Gadoterate Meglumine Sales (2021-2032) & (K L) Figure 18. Global Gadoterate Meglumine Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 19. Global Gadoterate Meglumine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Gadoterate Meglumine Sales YoY (2021-2032) & (K L) Figure 21. Europe Gadoterate Meglumine Sales YoY (2021-2032) & (K L) Figure 22. China Gadoterate Meglumine Sales YoY (2021-2032) & (K L) Figure 23. Asia (Excluding China) Gadoterate Meglumine Sales YoY (2021-2032) & (K L) Figure 24. South America, Middle East and Africa Gadoterate Meglumine Sales YoY (2021-2032) & (K L) Figure 25. Global Gadoterate Meglumine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Gadoterate Meglumine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Gadoterate Meglumine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Gadoterate Meglumine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Gadoterate Meglumine Revenue Market Share by Type (2021-2032) Figure 31. Global Gadoterate Meglumine Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 32. Global Gadoterate Meglumine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Gadoterate Meglumine Sales Market Share by Type (2021-2032) Figure 34. Global Gadoterate Meglumine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Gadoterate Meglumine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Gadoterate Meglumine Revenue Market Share by Application (2021-2032) Figure 37. Global Gadoterate Meglumine Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 38. Global Gadoterate Meglumine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Gadoterate Meglumine Sales Market Share by Application (2021-2032) Figure 40. North America Gadoterate Meglumine Revenue Share by Type (2021-2032) Figure 41. North America Gadoterate Meglumine Sales Share by Type (2021-2032) Figure 42. North America Gadoterate Meglumine Revenue Share by Application (2021-2032) Figure 43. North America Gadoterate Meglumine Sales Share by Application (2021-2032) Figure 44. North America Gadoterate Meglumine Revenue Share by Country (2021-2032) Figure 45. North America Gadoterate Meglumine Sales Share by Country (2021-2032) Figure 46. Europe Gadoterate Meglumine Revenue Share by Type (2021-2032) Figure 47. Europe Gadoterate Meglumine Sales Share by Type (2021-2032) Figure 48. Europe Gadoterate Meglumine Revenue Share by Application (2021-2032) Figure 49. Europe Gadoterate Meglumine Sales Share by Application (2021-2032) Figure 50. Europe Gadoterate Meglumine Revenue Share by Country (2021-2032) Figure 51. Europe Gadoterate Meglumine Sales Share by Country (2021-2032) Figure 52. China Gadoterate Meglumine Revenue Share by Type (2021-2032) Figure 53. China Gadoterate Meglumine Sales Share by Type (2021-2032) Figure 54. China Gadoterate Meglumine Revenue Share by Application (2021-2032) Figure 55. China Gadoterate Meglumine Sales Share by Application (2021-2032) Figure 56. Asia Gadoterate Meglumine Revenue Share by Type (2021-2032) Figure 57. Asia Gadoterate Meglumine Sales Share by Type (2021-2032) Figure 58. Asia Gadoterate Meglumine Revenue Share by Application (2021-2032) Figure 59. Asia Gadoterate Meglumine Sales Share by Application (2021-2032) Figure 60. Asia Gadoterate Meglumine Revenue Share by Country (2021-2032) Figure 61. Asia Gadoterate Meglumine Sales Share by Country (2021-2032) Figure 62. SAMEA Gadoterate Meglumine Revenue Share by Type (2021-2032) Figure 63. SAMEA Gadoterate Meglumine Sales Share by Type (2021-2032) Figure 64. SAMEA Gadoterate Meglumine Revenue Share by Application (2021-2032) Figure 65. SAMEA Gadoterate Meglumine Sales Share by Application (2021-2032) Figure 66. SAMEA Gadoterate Meglumine Revenue Share by Country (2021-2032) Figure 67. SAMEA Gadoterate Meglumine Sales Share by Country (2021-2032) Figure 68. Gadoterate Meglumine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Gadoterate Meglumine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5.6535Gm/15Ml
  • 3.769Gm/10Ml
  • 1.8845Gm/5Ml
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Hengrui Medicine
  • Guerbet Group
  • GE Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gadoterate Meglumine Market by Type
  3. 1.2.1 Global Gadoterate Meglumine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5.6535Gm/15Ml
  5. 1.2.3 3.769Gm/10Ml
  6. 1.2.4 1.8845Gm/5Ml
  7. 1.2.5 Others
  8. 1.3 Gadoterate Meglumine Market by Application
  9. 1.3.1 Global Gadoterate Meglumine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Clinics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Gadoterate Meglumine Market Dynamics
  1. 2.1 Gadoterate Meglumine Industry Trends
  2. 2.2 Gadoterate Meglumine Industry Drivers
  3. 2.3 Gadoterate Meglumine Industry Opportunities and Challenges
  4. 2.4 Gadoterate Meglumine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gadoterate Meglumine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gadoterate Meglumine Revenue by Region
  3. 3.2.1 Global Gadoterate Meglumine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gadoterate Meglumine Revenue by Region (2021-2026)
  5. 3.2.3 Global Gadoterate Meglumine Revenue by Region (2027-2032)
  6. 3.2.4 Global Gadoterate Meglumine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gadoterate Meglumine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gadoterate Meglumine Sales by Region
  9. 3.4.1 Global Gadoterate Meglumine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gadoterate Meglumine Sales by Region (2021-2026)
  11. 3.4.3 Global Gadoterate Meglumine Sales by Region (2027-2032)
  12. 3.4.4 Global Gadoterate Meglumine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gadoterate Meglumine Revenue by Manufacturers
  2. 4.1.1 Global Gadoterate Meglumine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gadoterate Meglumine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gadoterate Meglumine Sales by Manufacturers
  6. 4.2.1 Global Gadoterate Meglumine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gadoterate Meglumine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gadoterate Meglumine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gadoterate Meglumine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gadoterate Meglumine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gadoterate Meglumine Manufacturers, Product Type & Application
  13. 4.7 Global Gadoterate Meglumine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gadoterate Meglumine Market CR5 and HHI
  16. 4.8.2 2025 Gadoterate Meglumine Tier 1, Tier 2, and Tier 3
5 Gadoterate Meglumine Market by Type
  1. 5.1 Global Gadoterate Meglumine Revenue by Type
  2. 5.1.1 Global Gadoterate Meglumine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gadoterate Meglumine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gadoterate Meglumine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gadoterate Meglumine Sales by Type
  6. 5.2.1 Global Gadoterate Meglumine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gadoterate Meglumine Sales by Type (2021-2032) & (K L)
  8. 5.2.3 Global Gadoterate Meglumine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gadoterate Meglumine Price by Type
6 Gadoterate Meglumine Market by Application
  1. 6.1 Global Gadoterate Meglumine Revenue by Application
  2. 6.1.1 Global Gadoterate Meglumine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gadoterate Meglumine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gadoterate Meglumine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gadoterate Meglumine Sales by Application
  6. 6.2.1 Global Gadoterate Meglumine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gadoterate Meglumine Sales by Application (2021-2032) & (K L)
  8. 6.2.3 Global Gadoterate Meglumine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gadoterate Meglumine Price by Application
7 Company Profiles
  1. 7.1 Hengrui Medicine
  2. 7.1.1 Hengrui Medicine Company Information
  3. 7.1.2 Hengrui Medicine Business Overview
  4. 7.1.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
  6. 7.1.5 Hengrui Medicine Recent Developments
  7. 7.2 Guerbet Group
  8. 7.2.1 Guerbet Group Company Information
  9. 7.2.2 Guerbet Group Business Overview
  10. 7.2.3 Guerbet Group Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Guerbet Group Gadoterate Meglumine Product Portfolio
  12. 7.2.5 Guerbet Group Recent Developments
  13. 7.3 GE Healthcare
  14. 7.3.1 GE Healthcare Company Information
  15. 7.3.2 GE Healthcare Business Overview
  16. 7.3.3 GE Healthcare Gadoterate Meglumine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GE Healthcare Gadoterate Meglumine Product Portfolio
  18. 7.3.5 GE Healthcare Recent Developments
8 North America
  1. 8.1 North America Gadoterate Meglumine Market Size by Type
  2. 8.1.1 North America Gadoterate Meglumine Revenue by Type (2021-2032)
  3. 8.1.2 North America Gadoterate Meglumine Sales by Type (2021-2032)
  4. 8.1.3 North America Gadoterate Meglumine Price by Type (2021-2032)
  5. 8.2 North America Gadoterate Meglumine Market Size by Application
  6. 8.2.1 North America Gadoterate Meglumine Revenue by Application (2021-2032)
  7. 8.2.2 North America Gadoterate Meglumine Sales by Application (2021-2032)
  8. 8.2.3 North America Gadoterate Meglumine Price by Application (2021-2032)
  9. 8.3 North America Gadoterate Meglumine Market Size by Country
  10. 8.3.1 North America Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gadoterate Meglumine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gadoterate Meglumine Market Size by Type
  2. 9.1.1 Europe Gadoterate Meglumine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gadoterate Meglumine Sales by Type (2021-2032)
  4. 9.1.3 Europe Gadoterate Meglumine Price by Type (2021-2032)
  5. 9.2 Europe Gadoterate Meglumine Market Size by Application
  6. 9.2.1 Europe Gadoterate Meglumine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gadoterate Meglumine Sales by Application (2021-2032)
  8. 9.2.3 Europe Gadoterate Meglumine Price by Application (2021-2032)
  9. 9.3 Europe Gadoterate Meglumine Market Size by Country
  10. 9.3.1 Europe Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gadoterate Meglumine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gadoterate Meglumine Market Size by Type
  2. 10.1.1 China Gadoterate Meglumine Revenue by Type (2021-2032)
  3. 10.1.2 China Gadoterate Meglumine Sales by Type (2021-2032)
  4. 10.1.3 China Gadoterate Meglumine Price by Type (2021-2032)
  5. 10.2 China Gadoterate Meglumine Market Size by Application
  6. 10.2.1 China Gadoterate Meglumine Revenue by Application (2021-2032)
  7. 10.2.2 China Gadoterate Meglumine Sales by Application (2021-2032)
  8. 10.2.3 China Gadoterate Meglumine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gadoterate Meglumine Market Size by Type
  2. 11.1.1 Asia Gadoterate Meglumine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gadoterate Meglumine Sales by Type (2021-2032)
  4. 11.1.3 Asia Gadoterate Meglumine Price by Type (2021-2032)
  5. 11.2 Asia Gadoterate Meglumine Market Size by Application
  6. 11.2.1 Asia Gadoterate Meglumine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gadoterate Meglumine Sales by Application (2021-2032)
  8. 11.2.3 Asia Gadoterate Meglumine Price by Application (2021-2032)
  9. 11.3 Asia Gadoterate Meglumine Market Size by Country
  10. 11.3.1 Asia Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gadoterate Meglumine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gadoterate Meglumine Market Size by Type
  2. 12.1.1 SAMEA Gadoterate Meglumine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gadoterate Meglumine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gadoterate Meglumine Price by Type (2021-2032)
  5. 12.2 SAMEA Gadoterate Meglumine Market Size by Application
  6. 12.2.1 SAMEA Gadoterate Meglumine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gadoterate Meglumine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gadoterate Meglumine Price by Application (2021-2032)
  9. 12.3 SAMEA Gadoterate Meglumine Market Size by Country
  10. 12.3.1 SAMEA Gadoterate Meglumine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gadoterate Meglumine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gadoterate Meglumine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gadoterate Meglumine Value Chain Analysis
  2. 13.1.1 Gadoterate Meglumine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gadoterate Meglumine Production Mode & Process
  6. 13.2 Gadoterate Meglumine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gadoterate Meglumine Distributors
  9. 13.2.3 Gadoterate Meglumine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst